Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study

被引：0
|
作者：
Bosch, Francesc [1 ]
Foa, Robin [2 ]
Cortelezzi, Agostino [3 ]
Kisro, Jens [4 ]
Leblond, Veronique [5 ]
Tumyan, Gayane [6 ]
Gresko, Ekaterina [7 ]
Robson, Susan [7 ]
Stilgenbauer, Stephan [8 ]
机构：
[1] Univ Hosp Vall Hebron, Dept Hematol, Barcelona, Spain
[2] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Policlin Umberto 1, Rome, Italy
[3] Univ Milan, Milan, Italy
[4] Oncol Practice, Lubeck, Germany
[5] AP HP Hop Pitie Salpetriere, Dept Clin Hematol, Paris, France
[6] N N Blokhin Russian Canc Res Ctr, Moscow, Russia
[7] F Hoffmann Roche Ltd, Basel, Switzerland
[8] Ulm Univ Med Ctr, Dept Internal Med 3, Ulm, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5589.5589
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5589
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab
    Dawson, Keith
    Moran, Mollie
    Guindon, Kathleen
    Wan, Hui
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (02) : E41 - E48
  • [2] Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels
    Lujan, Juliana Velez
    Lengerke-Diaz, Paula A.
    Jacobs, Chaja
    Moreno-Cortes, Eider F.
    Ramirez-Segura, Cesar A.
    Choi, Michael Y.
    McCarthy, Colin
    Heinen, Alaina
    Kipps, Thomas J.
    Castro, Januario E.
    [J]. HAEMATOLOGICA, 2020, 105 (01) : E22 - E25
  • [3] RITUXIMAB INFUSION-RELATED TOXICITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Motyckova, M.
    Belada, D.
    Maly, J.
    Smolej, L.
    [J]. HAEMATOLOGICA, 2012, 97 : 525 - 525
  • [4] Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
    Freeman, Ciara L.
    Morschhauser, Franck
    Sehn, Laurie
    Dixon, Mark
    Houghton, Richard
    Lamy, Thierry
    Fingerle-Rowson, Guenter
    Wassner-Fritsch, Elisabeth
    Gribben, John G.
    Hallek, Michael
    Salles, Gilles
    Cartron, Guillaume
    [J]. BLOOD, 2015, 126 (24) : 2646 - 2649
  • [5] Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR)
    Freeman, Ciara Louise
    Morschhauser, Franck
    Sehn, Laurie H.
    Dixon, Mark
    Houghton, Richard
    Lamy, Thierry
    Fingerle-Rowson, Gunter
    Wassner-Fritsch, Elisabeth
    Hallek, Michael
    Salles, Gilles
    Cartron, Guillaume
    [J]. BLOOD, 2014, 124 (21)
  • [6] Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab
    Yosuke Masamoto
    Kazuki Taoka
    Hiroaki Maki
    Mineo Kurokawa
    [J]. Annals of Hematology, 2022, 101 : 2795 - 2797
  • [7] Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab
    Masamoto, Yosuke
    Taoka, Kazuki
    Maki, Hiroaki
    Kurokawa, Mineo
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2795 - 2797
  • [8] Tocilizumab to Prevent Infusion-Related Events in Patients with Chronic Lymphocytic Leukemia and Co-Morbidities Treated with Obinutuzumab and Chlorambucil: Results from the Randomized Phase Ib GALACTA Trial
    Freeman, Ciara Louise
    Boettcher, Sebastian
    De la Serna, Javier
    Delgado, Julio
    Falzetti, Franca
    Gobbi, Marco
    Lejniece, Sandra
    Di Bernardo, Maria Chiara
    Mallalieu, Navita L.
    Nielsen, Tina
    Knapp, Andrea
    Gribben, John G.
    [J]. BLOOD, 2018, 132
  • [9] Pattern of cytokine release in patients with chronic lymphocytic leukaemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR)
    Freeman, C.
    Morschhauser, F.
    Sehn, L.
    Dixon, M.
    Houghton, R.
    Lamy, T.
    Fingerle-Rowson, G.
    Wassner-Fritsch, E.
    Hallek, M.
    Salles, G.
    Cartron, G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 64 - 64
  • [10] Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study
    Park, Keunchil
    Sabari, Joshua
    Haura, Eric B.
    Shu, Catherine A.
    Spira, Alexander
    Salgia, Ravi
    Reckamp, Karen L.
    Sanborn, Rachel E.
    Govindan, Ramaswamy
    Bauml, Joshua M.
    Curtin, Joshua C.
    Xie, John
    Roshak, Amy
    Lorenzini, Patricia
    Millington, Dawn
    Thayu, Meena
    Knoblauch, Roland E.
    Cho, Byoung Chul
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S482 - S482
12345